antivirals

The spike protein on the SARS-CoV-2 virus up close

Protease inhibitor outperforms Paxlovid protecting lungs of mice

An oral drug developed by Stanford University researchers may be superior to Pfizer’s Paxlovid at reducing the severity of COVID-19, at least in mice.

Helen Floersh Mar 14, 2024 6:30am

A graphic of a persons outstretched hand with virus particles surrounding it

COVID-19 Moonshot pioneers explain success of open innovation

Nov 27, 2023 10:00am

GSK gives early look at HIV bNAb's power

Oct 25, 2022 10:00am

Cytomegalovirus CMV herpes herpesvirus virus

New antiviral class could halt treatment-resistant viruses

May 16, 2022 3:10pm

AbbVie, Scripps prep for endemic COVID-19 with antiviral collab

Mar 15, 2022 11:29am